In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and m cells of the canine ventricle

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 12, Issue 4, 2007, Pages 314-321

  Moro, Sandra ^a   Ferreiro, Marcela ^a   Celestino, Daniela ^a   Medei, Emiliano ^a   Elizari, Marcelo V ^a   Sicouri, Serge ^a,b  

^a HOSPITAL RAMOS MEJÍA   (Argentina)

^b NONE   (United States)

Author keywords

Antiarrhythmic drugs; Early afterdepolarizations; Transmural dispersion of repolarization

Indexed keywords

AMIODARONE; DRONEDARONE; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG MECHANISM; ENDOCARDIUM; EPICARDIUM; HEART DEPOLARIZATION; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; HEART VENTRICLE; IN VITRO STUDY; MALE; MICROELECTRODE; MUSCLE ACTION POTENTIAL; NONHUMAN; PRIORITY JOURNAL;

ACTION POTENTIALS; AMIODARONE; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOGS; ENDOCARDIUM; HEART VENTRICLES; MALE; MYOCARDIUM; PERICARDIUM; SOTALOL; VENTRICULAR FUNCTION, LEFT;

EID: 37249076620     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248407306906     Document Type: Article

References (36)

1. Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 ; 38: 934-944.
2. Weinberg BA, Miles WM, Klein LS, et al. Five-year follow-up of 589 patients treated with amiodarone. Am Heart J. 1993 ; 125: 109-120.
3. Singh BN, Vaughan-Williams EM The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 ; 39: 657-667.
4. Varro A., Nakaya Y., Elharrar V., Surawicz B. Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers. Eur J Pharmcol. 1985 ; 112: 419-422.
5. Kadish AH, Chen R-F., Schmaltz S., Morady F. Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. J Am Coll Cardiol. 1990 ; 16: 1240-1245.
6. Nattel S., Talajic M., Quantz MA, De RoodeMR Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel blocking activities. Circulation. 1987 ; 76: 442-449.
7. Patterson E., Eller BT, Abrams GD, Vasiliades J., Lucchesi BR Ventricular fibrillation in a conscious canine preparation of sudden coronary death-prevention by short- and long-term amiodarone administration. Circulation. 1983 ; 68: 857-864.
8. Gallagher JD, Bianchi J., Gessman LJ A comparison of the electrophysiological effects of acute and chronic amiodarone administration on canine Purkinje fibers. J Cardiovasc Pharmacol. 1989 ; 13: 723-729.
9. Yabek SM, Kato R., Singh BN Acute effects of amiodarone on the electrophysiologic properties of isolated neonatal and adult cardiac fibers. J Am Coll Cardiol. 1985 ; 5: 1109-1115.
10. Hohnloser SH, Klingenheben T., Singh BN Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994 ; 121: 529-535.
11. Sicouri S., Moro S., Litovsky SH, Elizari MV, Antzelevitch C. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol. 1997 ; 8: 1269-1279.
12. Martin W., Rosenow E. Amiodarone pulmonary toxicity recognition and pathogenesis. Chest. 1988 ; 93: 1067-1075.
13. Chatelain P., Meysmans L., Matteazzi JR, Beaufort P., Clinet M. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol. 1995 ; 116: 1949-1956.
14. Finance O., Manning A., Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol. 1995 ; 26: 570-576.
15. Manning AS, Bruyninckx C., Ramboux J., Chatelain P. SR 33589, a new amiodarone-like agent: effect on ischemia-and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol. 1995 ; 26: 453-461.
16. Hodeige D., Heyndrickx JP, Chatelain P., Manning A. SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anesthetized and conscious dogs. Eur J Pharmacol. 1995 ; 279: 25-32.
17. Manning A., Thisse V., Hodeige D., Richard J., Heyndrickx JP, Chatelain P. SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol. 1995 ; 25: 252-261.
18. Stark G., Stark U., Windisch H., et al. Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts. Basic Res Cardiol. 1991 ; 86: 136-147.
19. Morady F., Dicarlo LA, Krol RB, Baerman JM, De Buitleir M. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. J Am Coll Cardiol. 1986 ; 7: 148-157.
20. Singh BN Amiodarone: historical development and pharmacologic profile. Am Heart J. 1983 ; 106: 788-797.
21. Eddlestone GT, Zygmunt AC, Antzelevitch C. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol. 2001 ; 281: H689-697.
22. Papp JG, Nemeth M., Krassoi I., Mester L., Hala O., Varro A. Differential electrophysiologic effects of chronically administered amiodarone on canine Purkinje fibers versus ventricular muscle. J Cardiovasc Pharmacol Ther. 1996 ; 4: 287-296.
23. Kamiya K., Nishiyama A., Yasui K., Hojo M., Sanguinetti MC, Kodama I. Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current. Circulation. 2001 ; 103: 1317-1324.
24. Antzelevitch C., Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: the role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol. 1994 ; 23: 259-277.
25. Sicouri S., Moro S., Elizari MV d-Sotalol induces marked action potential prolongation and early afterdepolarizations in M but not epicardial or endocardial cells of the canine ventricle. J Cardiovasc Pharmacol Ther. 1997 ; 2: 27-38.
26. Varro A., Takacs J., Nemeth M., et al. Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br J Pharmacol. 2001 ; 133: 625-634.
27. Verduyn SC, Vos MA, Leunissen HD, van Opstal JM, Wellens HJ Evaluation of the acute electrophysiological effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias. J Cardiovasc Pharmacol. 1999 ; 33 ; 212-222.
28. van Opstal JM, Schoenmakers M., Verduyn SC, et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation. 2001 ; 104: 2722-2727.
29. Lalevee N., Nargeot J., Barrere-Lemaire S., Gautier P., Richard S. Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol. 2003 ; 14: 885-890.
30. Drouin E., Charpentier F., Gauthier C., Laurent K., Le Marec H. Electrophysiological characteristics of cells spanning the left ventricular wall of the human heart: evidence for the presence of M cells. J Am Coll Cardiol. 1995 ; 26: 185-192.
31. Sicouri S., Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle: the M cell. Circ Res. 1991 ; 68: 1729-1741.
32. Liu DW, Antzelevitch C. Characteristics of the delayed rectifier current (IKr and I Ks) in canine ventricular epicardial, midmyocardial and endocardial myocytes: a weaker IKs contributes to the longer action potential of the M cell. Circ Res. 1995 ; 76: 351-365.
33. Thomas D., Kathofer S., Zhang W., et al. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol. 2003 ; 140: 996-1002. Epub September 29, 2003.
34. Gautier P., Marion A., Bertrand JP, Tourneur Y., Nisato D. Electrophysiological characterization of dronedarone (SR33589), a new amiodarone-like agent, in cardiac ventricular myocytes. J Cardiovasc Pharmacol. 2003 ; 41: 191-202.
35. Touboul P., Brugada J., Capucci A., et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J. 2003 ; 24: 1481-1487.
36. Celestino D., Medei E., Moro S., Elizari MV, Sicouri S. Acute in vitro effects of dronedarone, an iodine-free derivative and amiodarone, on the rabbit sinoatrial node automaticity. A comparative study. J Cardiovasc Pharmacol Ther. In press.